Diaz-Rubio E - Search Results

1

Phase II study of pegylated liposomal doxorubicin plus vinorelbine in breast cancer with previous anthracycline exposure.

Martin M, García-Donas J, Casado A, de la Gándara I, Pérez-Segura P, García-Saenz JA, Ibáñez G, Loboff B, García-Ledo G, Moreno F, Grande E, Diaz-Rubio E. Martin M, et al. Clin Breast Cancer. 2004 Dec;5(5):353-7. doi: 10.3816/cbc.2004.n.041. Clin Breast Cancer. 2004. PMID: 15585072 Clinical Trial.

2

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T. de la Hoya M, et al. Int J Cancer. 2002 Feb 1;97(4):466-71. doi: 10.1002/ijc.1627. Int J Cancer. 2002. PMID: 11802208

3

Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.

Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E. Caldes T, et al. Int J Cancer. 2002 Apr 10;98(5):774-9. doi: 10.1002/ijc.10240. Int J Cancer. 2002. PMID: 11920650

4

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

Bellmunt J, Albanell J, Paz-Ares L, Climent MA, González-Larriba JL, Carles J, de la Cruz JJ, Guillem V, Díaz-Rubio E, Cortés-Funes H, Baselga J; Spanish Oncology Genitourinary Group. Bellmunt J, et al. Cancer. 2002 Aug 15;95(4):751-7. doi: 10.1002/cncr.10762. Cancer. 2002. PMID: 12209718 Free article. Clinical Trial.

5

Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both.

de la Hoya M, Fernández JM, Tosar A, Godino J, Sánchez de Abajo A, Vidart JA, Pérez-Segura P, Díaz-Rubio E, Caldés T. de la Hoya M, et al. JAMA. 2003 Aug 20;290(7):929-31. doi: 10.1001/jama.290.7.929. JAMA. 2003. PMID: 12928470

6

5-fluorouracil as a protracted continuous infusion plus irinotecan (CPT-11) in patients with advanced colorectal cancer treated with fluoropyrimidine-based regimens as first line.

Sastre J, Alfonso R, Macías JA, Manrique I, Flores L, Díaz-Rubio E. Sastre J, et al. Anticancer Drugs. 2003 Aug;14(7):543-7. doi: 10.1097/00001813-200308000-00006. Anticancer Drugs. 2003. PMID: 12960738 Clinical Trial.

7

Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors.

Abad A, Massutí B, Gallego J, Yuste AL, Manzano JL, Carrato A, Antón A, Marfa X, Diaz-Rubio E; Spanish Cooperative Group for Gastrointestinal Tumor Therapy. Abad A, et al. Anticancer Drugs. 2004 Jun;15(5):469-71. doi: 10.1097/01.cad.0000127146.50172.8a. Anticancer Drugs. 2004. PMID: 15166620 Clinical Trial.

8

[The epidemiology of asymptomatic pulmonary embolism in cancer patients].

Moreno Antón F, Grande Pulido E, Pérez Segura P, Díaz Rubio E. Moreno Antón F, et al. Med Clin (Barc). 2004 Oct 16;123(13):516. doi: 10.1016/s0025-7753(04)74576-5. Med Clin (Barc). 2004. PMID: 15511377 Spanish. No abstract available.

9

Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer.

Abad A, Carrato A, Navarro M, Sastre J, Cervantes A, Antón A, Martinez-Villacampa M, Marcuello E, Massutí B, Aranda E, Manzano JL, Guallar JL, Diaz-Rubio E. Abad A, et al. Clin Colorectal Cancer. 2005 Mar;4(6):384-9. doi: 10.3816/ccc.2005.n.010. Clin Colorectal Cancer. 2005. PMID: 15807931 Clinical Trial.

10

A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours.

Sastre J, Paz-Ares L, Carcas A, Alfonso R, Grávalos C, Frías J, Guerra P, Pronk L, Cortés-Funes H, Díaz-Rubio E. Sastre J, et al. Cancer Chemother Pharmacol. 2005 May;55(5):453-60. doi: 10.1007/s00280-004-0915-x. Epub 2004 Oct 26. Cancer Chemother Pharmacol. 2005. PMID: 15818508 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters